NCT06251895View on ClinicalTrials.gov

Association of Systemic Immune-inflammation Index and Severity of Diabetic Ketoacidosis in Type 1 Diabetes Mellitus

CompletedOBSERVATIONAL

Enrollment

241

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 31, 2022

Study Completion Date

November 11, 2023

Conditions

Diabetic Ketoacidosis

Interventions

OTHER

DKA protocol

IV fluids and IV insulin as per guidelines. reference 1-2

Trial Locations (1)

2675

Jahra Hospital, Kuwait

All Listed Sponsors

lead

Jahra Hospital

OTHER